DK3647306T3 - 4-Oxo-alkyleret tetramsyreforbindelse og fremgangsmåde til fremstilling deraf - Google Patents
4-Oxo-alkyleret tetramsyreforbindelse og fremgangsmåde til fremstilling deraf Download PDFInfo
- Publication number
- DK3647306T3 DK3647306T3 DK18843726.3T DK18843726T DK3647306T3 DK 3647306 T3 DK3647306 T3 DK 3647306T3 DK 18843726 T DK18843726 T DK 18843726T DK 3647306 T3 DK3647306 T3 DK 3647306T3
- Authority
- DK
- Denmark
- Prior art keywords
- oxo
- preparation
- acid compound
- tetramic acid
- alkylated
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/36—Oxygen or sulfur atoms
- C07D207/38—2-Pyrrolones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201710684334.9A CN107353239B (zh) | 2017-08-11 | 2017-08-11 | 4-氧-烷基化特特拉姆酸类化合物及其制备方法 |
| PCT/CN2018/091962 WO2019029274A1 (zh) | 2017-08-11 | 2018-06-20 | 4-氧-烷基化特特拉姆酸类化合物及其制备方法 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK3647306T3 true DK3647306T3 (da) | 2022-06-27 |
Family
ID=60287057
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK18843726.3T DK3647306T3 (da) | 2017-08-11 | 2018-06-20 | 4-Oxo-alkyleret tetramsyreforbindelse og fremgangsmåde til fremstilling deraf |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US11332440B2 (da) |
| EP (1) | EP3647306B1 (da) |
| CN (1) | CN107353239B (da) |
| AU (1) | AU2018314472B9 (da) |
| DK (1) | DK3647306T3 (da) |
| ES (1) | ES2920132T3 (da) |
| HU (1) | HUE059136T2 (da) |
| PT (1) | PT3647306T (da) |
| WO (1) | WO2019029274A1 (da) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107468690B (zh) | 2017-08-11 | 2020-01-31 | 北京卓凯生物技术有限公司 | 4-氧-烷基化特特拉姆酸类化合物及其制备方法与应用 |
| CN107353239B (zh) * | 2017-08-11 | 2019-06-18 | 北京卓凯生物技术有限公司 | 4-氧-烷基化特特拉姆酸类化合物及其制备方法 |
| CN112409234A (zh) * | 2020-11-30 | 2021-02-26 | 北京卓凯生物技术有限公司 | 一种左旋氟吡咯酮的晶型a及其制备方法 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0529483B1 (de) | 1991-08-22 | 1996-02-28 | Lonza Ag | Verfahren zur Herstellung von optisch aktiven 4-Amino-3-hydroxycarbonsäuren |
| GB9210393D0 (en) * | 1992-05-15 | 1992-07-01 | Merck Sharp & Dohme | Therapeutic agents |
| DE10354629A1 (de) | 2003-11-22 | 2005-06-30 | Bayer Cropscience Ag | 2-Ethyl-4,6-dimethyl-phenyl substituierte spirocyclische Tetramsäure-Derivate |
| RU2006122851A (ru) | 2003-11-28 | 2008-01-10 | Ф.Хоффманн-Ля Рош Аг (Ch) | Тетроновая кислота и тетрамовая кислота-ингибиторы бета-секретазы |
| EP1992614A1 (de) | 2007-05-16 | 2008-11-19 | Bayer CropScience Aktiengesellschaft | 3-(2-Alkoxy-phenyl)-substituierte Tetramate |
| JP2012500778A (ja) | 2008-08-22 | 2012-01-12 | ブリティッシュ コロンビア キャンサー エージェンシー ブランチ | アンドロゲン受容体のｎ末端の活性化の小分子阻害剤 |
| US8389443B2 (en) | 2008-12-02 | 2013-03-05 | Bayer Cropscience Ag | Geminal alkoxy/alkylspirocyclic substituted tetramate derivatives |
| CN101838260B (zh) * | 2010-03-31 | 2013-08-14 | 华南理工大学 | 二氢吡咯酮衍生物作为Caspase-3抑制剂 |
| CN106905215B (zh) | 2011-01-25 | 2021-10-01 | 拜耳知识产权有限责任公司 | 制备1-h-吡咯烷-2,4-二酮衍生物的方法 |
| EA027136B1 (ru) | 2012-07-02 | 2017-06-30 | Пнб Веспер Лайф Сайенс Пвт Лимитед | Новые лиганды холецистокининовых рецепторов |
| US10202355B2 (en) * | 2013-02-12 | 2019-02-12 | Buck Institute For Research On Aging | Hydantoins that modulate bace-mediated app processing |
| CN107056672A (zh) | 2017-05-22 | 2017-08-18 | 北京卓凯生物技术有限公司 | 吡咯烷‑2,4‑二酮类化合物及其制备方法 |
| CN107353239B (zh) | 2017-08-11 | 2019-06-18 | 北京卓凯生物技术有限公司 | 4-氧-烷基化特特拉姆酸类化合物及其制备方法 |
| CN107468690B (zh) | 2017-08-11 | 2020-01-31 | 北京卓凯生物技术有限公司 | 4-氧-烷基化特特拉姆酸类化合物及其制备方法与应用 |
-
2017
- 2017-08-11 CN CN201710684334.9A patent/CN107353239B/zh active Active
-
2018
- 2018-06-20 EP EP18843726.3A patent/EP3647306B1/en active Active
- 2018-06-20 WO PCT/CN2018/091962 patent/WO2019029274A1/zh unknown
- 2018-06-20 ES ES18843726T patent/ES2920132T3/es active Active
- 2018-06-20 HU HUE18843726A patent/HUE059136T2/hu unknown
- 2018-06-20 US US16/637,609 patent/US11332440B2/en active Active
- 2018-06-20 PT PT188437263T patent/PT3647306T/pt unknown
- 2018-06-20 DK DK18843726.3T patent/DK3647306T3/da active
- 2018-06-20 AU AU2018314472A patent/AU2018314472B9/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| AU2018314472B2 (en) | 2020-08-27 |
| EP3647306A4 (en) | 2021-04-07 |
| PT3647306T (pt) | 2022-07-01 |
| EP3647306A1 (en) | 2020-05-06 |
| EP3647306B1 (en) | 2022-04-06 |
| CN107353239A (zh) | 2017-11-17 |
| ES2920132T3 (es) | 2022-08-01 |
| AU2018314472A1 (en) | 2020-02-13 |
| AU2018314472B9 (en) | 2020-09-17 |
| HUE059136T2 (hu) | 2022-10-28 |
| US20200181081A1 (en) | 2020-06-11 |
| CN107353239B (zh) | 2019-06-18 |
| US11332440B2 (en) | 2022-05-17 |
| WO2019029274A1 (zh) | 2019-02-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK3312177T3 (da) | Tricyklisk derivatforbindelse, fremgangsmåde til at fremstille samme og farmaceutisk sammensætning omfattende samme | |
| DK3292150T3 (da) | Aktiverbare anti-cd166-antistoffer og fremgangsmåder til anvendelse deraf | |
| DK3325669T3 (da) | Sammensætninger og fremgangsmåder til RNA-analyse | |
| DK3376859T3 (da) | Mikroorganismer til fremstilling af insektferomoner og relaterede forbindelser | |
| DK3676297T3 (da) | Forbindelser, sammensætninger og fremgangsmåder | |
| DK3524595T3 (da) | Quinolinderivat af høj renhed og fremgangsmåde til fremstilling deraf | |
| DK3286181T3 (da) | Pyrazolforbindelser og fremgangsmåde til fremstilling og anvendelse af forbindelserne | |
| DK3524603T3 (da) | Fgfr4-hæmmer, fremgangsmåde til fremstilling deraf og farmaceutisk anvendelse deraf | |
| DK3621229T3 (da) | Fremgangsmåde til delvis retransmission | |
| DK3092256T3 (da) | Forbindelser og sammensætninger til immunterapi | |
| DK3072835T3 (da) | Fremgangsmåde til fremføring | |
| DK3294865T3 (da) | Fremgangsmåder til fremstilling af epimeraser og benzylisoquinolinalkaloider | |
| DK3204386T3 (da) | Substituerede aminopurinforbindelser, sammensætninger deraf og fremgangsmåder til behandling dermed | |
| DK3750893T3 (da) | Dioxazolinforbindelse, fremgangsmåde til fremstilling deraf og anvendelser deraf | |
| DK3371313T3 (da) | Fremgangsmåder og sammensætninger til forbedret plantetransformation | |
| DK3357343T3 (da) | Fedtsammensætning og fremgangsmåde til fremstilling heraf | |
| DK3424924T3 (da) | Ureaforbindelse, fremgangsmåde til fremstilling deraf og medicinsk anvendelse deraf | |
| DK3265443T3 (da) | Pyrrolidincarboxamidderivater og fremgangsmåde til fremstilling og anvendelse af samme | |
| DK3390427T3 (da) | Fremgangsmåde til fremstilling af degarelix og dets mellemprodukter | |
| DK3150710T3 (da) | Fremgangsmåde til fremstilling af homoserin-lacton og organisk syre fra mikroorganisme-afledt o-acyl-homoserin | |
| DK3706587T3 (da) | Acetatpulver og fremgangsmåde til fremstilling deraf | |
| EP3643311C0 (en) | 4-OXO-ALKYLATED TETRAMIC ACID COMPOUND, PROCESS FOR PREPARING THE SAME AND USE THEREOF | |
| DK3647306T3 (da) | 4-Oxo-alkyleret tetramsyreforbindelse og fremgangsmåde til fremstilling deraf | |
| DK3691649T3 (da) | Sammensætninger og fremgangsmåder til sårbehandling | |
| DK3323811T3 (da) | Fremgangsmåde til fremstilling af en nitrogen-holdig heterocyklisk forbindelse og mellemprodukt af den nitrogen-holdige heterocykliske forbindelse |